TXG

10x Genomics, Inc. (NASDAQ:TXG) is a life sciences technology company founded in 2012 and headquartered in Pleasanton, California. The company went public in September 2019 and has established itself as a leading provider of advanced genomics analysis tools. 10x Genomics develops and commercializes sophisticated instruments, consumables, and software that enable researchers to analyze biological systems at the cellular level with unprecedented detail. The company serves academic institutions, government research facilities, biotechnology companies, and pharmaceutical organizations across North America, Europe, the Middle East, Africa, China, and the Asia Pacific region.